ENDOXAN 500 mg, powder for solution for injection bottle
Active ingredients: Cyclophosphamide hydrate, Anhydrous cyclophosphamide hydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder and solvent for solution for injectionbottleintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ENDOXAN 500 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 500 mg
- Marketing authorisation holder
- BAXTER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Apr 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64635418CIP73211950CIP133400932119509Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYCLOPHOSPHAMIDEpoudre | 534,50 mg · un flacon | SA |
| CYCLOPHOSPHAMIDE ANHYDREpoudre | 500 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.